Trilogy Capital’s iShares China Large-Cap ETF FXI Stock Holding History

Trilogy Capital’s Portfolio FXI Stock Details FXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-200	Closed	-$9K	–	292
2018 Q3	$9K	Hold	200	–	–	﹤0.01%	337
2018 Q2	$9K	Hold	200	–	–	﹤0.01%	306
2018 Q1	$9K	Buy	+200	New	+$9.82K	﹤0.01%	272

Other funds holding FXI

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Trilogy Capital's FXI Position: Q4 2018 in Review

Trilogy Capital sold out of iShares China Large-Cap ETF (FXI) in Q4 2018, closing a stake of 200 shares — an estimated $9K sold.

Trilogy Capital first reported a position in FXI in Q1 2018 and held it in 3 quarters. The position peaked at $9K in Q3 2018. 289 funds tracked by Wall St. Rank hold FXI as of Q4 2018.

Trilogy Capital reported no remaining iShares China Large-Cap ETF position as of Q4 2018 after selling out during the quarter.
Trilogy Capital sold 200 iShares China Large-Cap ETF shares in Q4 2018, an estimated $9K.
Trilogy Capital first reported a position in iShares China Large-Cap ETF in Q1 2018 and held it in 3 quarters.
Trilogy Capital's iShares China Large-Cap ETF position peaked at $9K in Q3 2018.
289 funds tracked by Wall St. Rank held iShares China Large-Cap ETF as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.